Moderna

The two companies producing COVID-19 vaccines for use in the United States will have to raise production to meet contractual goals of 100 million doses each by the end of March.

President Biden has said he plans to invoke the Defense Production Act to provide more COVID vaccines, but forcing companies to gear up production won’t provide much-needed doses anytime soon.

In a new round of tests, the drug company wants to see if booster doses of its vaccine will ramp up defenses against emerging strains of the coronavirus.

Surgeon General Scott Rivkees says he does not know when additional “first doses” of the Pfizer and Moderna vaccines will be sent or how many doses would be in a potential future delivery.

The governor will announce a plan Tuesday for the second phase of vaccine distribution that will put seniors next in line to get shots, over first responders and general health care workers.

On the "Florida Roundup," host Melissa Ross spoke with Dr. Jason Wilson, associate director of Tampa General Hospital’s emergency department about his experience with the Pfizer vaccine.

Recent surveys have shown a large percentage of Americans don't plan to get the COVID-19 vaccine because they don't trust it, are afraid of getting sick, or aren't concerned with the virus.

The top military official with the federal vaccine effort spoke less than 24 hours after Moderna's COVID-19 vaccine became the second to win an emergency use authorization from the FDA.

The FDA greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.

Despite being founded a decade ago, Moderna has never had a product make it to market. And the company registered its first factory with the FDA this past week.